ESR2 and ovarian carcinoma: Given that OSU-ERb-12 can inhibit cell expansion in all cancer cell lines tested in this study at a similar efficacy, these results indicate that the killing of ovarian cancer cells by OSU-ERb-12 is independent of ERα expression.